ERBB2 and diabetes mellitus: Acute AG825 administration (10−5 M) also opposed the diabetes-induced elevation in phosphorlated ErbB2 (Y1221/1222), ROCK II (Y256) and ERK1/2 in the isolated mesenteric vascular bed (Figure 3b).